Third Rock Ventures V, L.P.'s Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed May 11, 2026
- Accession no.
- 0001193125-26-217092
- Filed
- May 11, 2026, 5:07 PM ET
- Trade date
- May 7-8, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $11.1M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Third Rock Ventures V, L.P.CIK 0001778071 | 10% Owner |
| Third Rock Ventures VI, L.P.CIK 0001931056 | 10% Owner |
| Third Rock Ventures GP V, LPCIK 0001977498 | 10% Owner |
| Third Rock Ventures GP VI, L.P.CIK 0001977499 | 10% Owner |
| TRV GP VI, LLCCIK 0001990716 | 10% Owner |
| TRV GP V, LLCCIK 0001990717 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Common Stock | SSaleDisposed | −271,495 | $40.12 | −$10,892,650.9 | 6,437,733 | Direct | |
| May 8, 2026 | Common Stock | SSaleDisposed | −5,018 | $40.31 | −$202,255.51 | 6,432,715 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.